NovaBridge Biosciences
Fundamentals
Oldest to newest| Line | Dec 2025 |
|---|---|
| Operating income | −$94.3M |
| Net income | −$46.3M |
| Operating cash flow | −$20.6M |
| Free cash flow | −$20.6M |
| Cash | $210.6M |
| Shares outstanding | 220.3M |
| Line | Dec 2025 |
|---|---|
| Operating income | −$94.3M |
| Net income | −$46.3M |
| Operating cash flow | −$20.6M |
| Free cash flow | −$20.6M |
| Cash | $210.6M |
| Shares outstanding | 220.3M |